- Home
- SXC vs PRME Comparison
SXC vs PRME Comparison
Compare SXC & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXC
- PRME
- Stock Information
- Founded
- SXC 1960
- PRME 2019
- Country
- SXC United States
- PRME United States
- Employees
- SXC N/A
- PRME N/A
- Industry
- SXC Steel/Iron Ore
- PRME Medicinal Chemicals and Botanical Products
- Sector
- SXC Industrials
- PRME Health Care
- Exchange
- SXC Nasdaq
- PRME Nasdaq
- Market Cap
- SXC 653.6M
- PRME 693.5M
- IPO Year
- SXC N/A
- PRME 2022
- Fundamental
- Price
- SXC $7.95
- PRME $5.12
- Analyst Decision
- SXC Strong Buy
- PRME Buy
- Analyst Count
- SXC 1
- PRME 6
- Target Price
- SXC $13.00
- PRME $8.88
- AVG Volume (30 Days)
- SXC 852.8K
- PRME 2.9M
- Earning Date
- SXC 10-30-2025
- PRME 11-11-2025
- Dividend Yield
- SXC 6.03%
- PRME N/A
- EPS Growth
- SXC 15.74
- PRME N/A
- EPS
- SXC 0.85
- PRME N/A
- Revenue
- SXC $1,846,200,000.00
- PRME $4,961,000.00
- Revenue This Year
- SXC N/A
- PRME $179.58
- Revenue Next Year
- SXC N/A
- PRME N/A
- P/E Ratio
- SXC $9.38
- PRME N/A
- Revenue Growth
- SXC N/A
- PRME 739.42
- 52 Week Low
- SXC $7.18
- PRME $1.11
- 52 Week High
- SXC $12.82
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- SXC 56.10
- PRME 72.49
- Support Level
- SXC $7.79
- PRME $3.09
- Resistance Level
- SXC $8.03
- PRME $4.18
- Average True Range (ATR)
- SXC 0.20
- PRME 0.35
- MACD
- SXC 0.05
- PRME 0.15
- Stochastic Oscillator
- SXC 84.26
- PRME 97.60
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.